Thomas Spencer, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Avekshan
    Topic: 
    Consultation (MGH Advisor)
    Date added: 
    01/25/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    The FDA; Department of Defense
    Topic: 
    Research Support (MGH PI)
    Date added: 
    01/25/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    ADHD Scales Royalty Licensing
    Topic: 
    Royalties (MGH Corporate Sponsored)
    Date added: 
    01/25/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Patent
    Ineligible company: 
    US patent (#61/233,686)
    Topic: 
    Non-Stimulant Treatment for ADHD (no license fees)
    Date added: 
    01/25/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Patent
    Ineligible company: 
    US patent (#61/233,686)
    Topic: 
    Stimulant Abuse Prevention (no license fees)
    Date added: 
    01/25/2022
Return to Child & Adolescent Psychopharmacology 2022